Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis.
Respiratory Drugs Global Market Size
The global respiratory drugs market was valued at $54.80 billion in 2017. North America was the largest geographic region in the respiratory diseases drugs market in 2017, accounting for $26.2 billion or 47.8% market share. The USA was the largest country in the market in 2017, accounting for $20.4 billion or 37.1% market share.
Respiratory Drugs Global Market Trend
Many companies in the respiratory diseases drugs market are strategically partnering and collaborating with other companies to broaden their product portfolio. These collaborations help drug manufacturing companies enhance their product strength in specific therapy areas.
Respiratory Drugs Global Market Segmentation
The respiratory drugs market is segmented into Anti-Asthmatics And COPD Drugs, and Cough And Cold Preparations Drugs.
Anti-Asthmatics And COPD Drug companies produce drugs that can be used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings.
Cough And Cold Preparations Drug companies produce drugs containing active ingredients such as acetaminophen, antihistamines, dextromethorphan, decongestants, and ethanol that can be used to treat cough and cold.
The major players in the global respiratory drugs market are GlaxosmithKline Plc., AstraZeneca Plc., Merck & Co., Novartis AG, and Johnson & Johnson.
The countries covered in the global respiratory drugs market are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Metabolic Disorders Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Alpha Mannosidosis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Gynecology Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Lung Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Kidney Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Interleukin Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Immunosuppressants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
$
4000
October 2020
Oncology Drugs Market Definition
The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.
The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Oncology drug manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
$
4000
November 2020
CAR-T Therapy Market Definition
The chimeric antigen receptor -T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat blood cancers.
CAR-T therapy is type of immunotherapy in which T-cells taken from patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.
Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
$
4000
May 2021
Dry Eye Medication Market Definition
The dry eye medication market consists of sales of dry eye drugs and other related services by entities (organizations, sole traders and partnerships) that manufacture dry eye medication (or drugs) used to treat dry eyes. The dry eye medication market covers drugs that are used in the treatment of diseases related to dry eyes, irritation, pain, and infection.
Dry eye is one of the most common eye related medical conditions; for example, an estimated 25 million Americans suffer from at least one symptom of dry eyes. It can be defined as the inability of human eyes to produce or maintain a sufficient quantity and quality of natural tears to lubricate the eyes. This can result in damage to the surface of the eyes, leading to pain, irritation, and inflammation, increase the risk of eye infection, and affect a person’s vision. Common disorders caused by dry eyes include keratoconjunctivitis sicca, evaporative dry eye disease, and aqueous dry eye disease. The market numbers in this briefing cover pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions, which are included in a separate report.
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
$
4000
May 2020
Ophthalmology Drugs Market Definition
The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.
The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Ophthalmologic drug manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
$
6000
July 2018
The pharmaceutical drug market consists of sales of goods and related services by entities (organizations, sole traders and partnerships) that produce and sell pharmaceutical drugs used to treat various diseases. This industry includes establishments that produce drugs such as cardiovascular drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs and other drugs used to treat cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others.
Musculoskeletal Drugs Market Global Briefing 2018
$
1000
January 2018
The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others.
Musculoskeletal Drugs Global Market Size
The global musculoskeletal drugs market was valued at $130.10 billion in 2017. North America was the largest geographic region in the musculoskeletal disorders drugs market in 2017, accounting for $41 billion or 31.5% market share. The USA was the largest country in the market in 2017, accounting for $19.4 billion or 14.9% market share.
Musculoskeletal Drugs Global Market Trend
Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis. In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.
Respiratory Drugs Market Global Briefing 2018
$
1000
January 2018
Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis.
Respiratory Drugs Global Market Size
The global respiratory drugs market was valued at $54.80 billion in 2017. North America was the largest geographic region in the respiratory diseases drugs market in 2017, accounting for $26.2 billion or 47.8% market share. The USA was the largest country in the market in 2017, accounting for $20.4 billion or 37.1% market share.
Respiratory Drugs Global Market Trend
Many companies in the respiratory diseases drugs market are strategically partnering and collaborating with other companies to broaden their product portfolio. These collaborations help drug manufacturing companies enhance their product strength in specific therapy areas.
Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
$
4000
February 2021
Antisense & RNAi Therapeutics Market Definition
The antisense and RNAi therapeutics market consists of sales of antisense and RNAi therapeutics by entities (organizations, sole traders, and partnerships) that develop and manufacture antisense and RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various diseases including cancer, infectious diseases, cardiovascular diseases, genetic disorders, respiratory disorders, and neurological disorders.
Two major methods are employed in RNA therapeutics: double stranded RNA-mediated interference (RNAi) and antisense oligonucleotides (ASO). Both these methods differ in composition and modes of action. These antisense oligonucleotides and siRNAs mainly target the ribonucleic acid (RNA), whereas small molecules and biologic drugs primarily target proteins due to their chemical properties and distinct molecular mechanism of action.
